fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

EU boost for vaccine production and paediatric use

Written by | 10 May 2021

Article written by Gary Finnegan. A flurry of activity at the European Medicines Agency (EMA) has provided a much-needed shot in the arm for European immunisation programmes. The… read more.

A single dose of either the Pfizer/BioNTech or the AstraZeneca/Oxford COVID-19 vaccines reduced household transmission by up to a half

Written by | 5 May 2021

A single dose of either the Pfizer/BioNTech or the AstraZeneca/Oxford COVID-19 vaccines reduced household transmission by up to a half, according to new research by Public Health England… read more.

Frequent internet use by older people during lockdown linked to mental health benefits

Written by | 2 May 2021

A new study from the University of Surrey has found that among people aged 55 to 75 more frequent use of the internet was beneficial for mental health… read more.

Pregnant women with COVID-19 face high mortality rate

Written by | 1 May 2021

In a worldwide study of 2,100 pregnant women, those who contracted COVID-19 during pregnancy were 20 times more likely to die than those who did not contract the… read more.

Johnson & Johnson single-shot COVID-19 vaccine phase III data published in New England Journal of Medicine

Written by | 28 Apr 2021

Johnson & Johnson announced publication in the New England Journal of Medicine of primary data from the Phase III ENSEMBLE clinical trial for its single-dose COVID-19 vaccine, developed… read more.

Flushing a public toilet? Don’t linger, because aerosolized droplets do!

Written by | 28 Apr 2021

Flushing a toilet can generate large quantities of microbe-containing aerosols depending on the design, water pressure or flushing power of the toilet.

FDA announce that vaccinations with JNJ 78436735 for COVID-19 can restart – Johnson & Johnson

Written by | 26 Apr 2021

Johnson & Johnson announced that vaccinations with JNJ 78436735, the Company’s COVID-19 single-shot vaccine, will resume for all adults aged 18 years and older in the U.S., under… read more.

DCGI (India) approves Sputnik V COVID 19 vaccine for emergency use in India – Dr Reddy’s Laboratories

Written by | 25 Apr 2021

Dr. Reddy’s Laboratories Ltd. announced that it has received the permission from the Drug Controller General of India (DCGI) to import the Sputnik vaccine into India for restricted… read more.

COVID-19 patients may only need one vaccine dose

Written by | 23 Apr 2021

People who have recovered from COVID-19 had a robust antibody response after the first mRNA vaccine dose, but little immune benefit after the second dose, according to new… read more.

Lessons from the Zimbabwe ivermectin experience

Written by | 23 Apr 2021

Reflecting on ivermectin use in Zimbabwe, Dr Jackie Stone describes how covid-19 is now under control and everyone has the drug in their home medicine cupboard. In patients… read more.

The patient experience of ivermectin

Written by | 22 Apr 2021

Interview and article by Christine Clark. Dr Jackie Stone describes how her own experiences of taking ivermectin for severe covid and those of others have provided further insights… read more.

Johnson & Johnson statement on COVID 19 vaccine

Written by | 21 Apr 2021

Johnson & Johnson Statement on COVID-19 Vaccine (Updated) :The safety and well-being of the people who use our products is a number one priority. We are aware of… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.